JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120383

UDP sodium salt (Uridine 5'-diphosphate), P2Y6 agonist. P2Y14 ligand.

Be the first to review this product! Submit a review

|

(1 Publication)

MW 470.11 Da, Purity >98%. Endogenous P2Y receptor agonist which preferentially activates P2Y6. Antagonist and agonist activities reported at human P2Y14 receptors. Potent full agonist at rat P2Y12 (EC50 = 350 nM).

View Alternative Names

DKFZp686M18273, G-protein coupled receptor 17, GPR17_HUMAN, P2Y-like receptor, Probable P2Y purinoceptor GPR 17, R12, UDP/CysLT receptor, Uracil nucleotide/cysteinyl leukotriene receptor

Key facts

CAS number

19817-91-5

Purity

>98%

Form

Solid

form

Molecular weight

470.11 Da

Molecular formula

C<sub>9</sub>H<sub>1</sub><sub>1</sub>N<sub>2</sub>Na<sub>3</sub>O<sub>1</sub><sub>2</sub>P<sub>2</sub>

PubChem

88264

Nature

Synthetic

Solubility

Soluble in water to 100 mM

Biochemical name

Uridine 5'-(trisodium pyrophosphate)

Biological description

Endogenous P2Y receptor agonist which preferentially activates P2Y6. Antagonist and agonist activities reported at human P2Y14 receptors. Potent full agonist at rat P2Y12 (EC50 = 350 nM).

Canonical smiles

C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)([O-])OP(=O)([O-])[O-])O)O.[Na+].[Na+].[Na+]

Isomeric smiles

C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])[O-])O)O.[Na+].[Na+].[Na+]

InChi

InChI=1S/C9H14N2O12P2.3Na/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(22-8)3-21-25(19,20)23-24(16,17)18;;;/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,10,12,15)(H2,16,17,18);;;/q;3*+1/p-3/t4-,6-,7-,8-;;;/m1.../s1

InChiKey

GFASEGWJDXDCKZ-LLWADOMFSA-K

IUPAC Name

trisodium;[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] phosphate

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

GPR17 also known as G protein-coupled receptor 17 is a member of the G protein-coupled receptor (GPCR) family. This receptor has a molecular weight of approximately 40 kDa. It is expressed in various tissues with significant levels found in the central nervous system including the brain and spinal cord. GPR17 also shows expression in kidneys liver and heart. It is classified under the class A Rhodopsin-like family and is an orphan receptor meaning its natural ligand is not completely established but is thought to be associated with uridine nucleotides and cysteinyl leukotrienes.
Biological function summary

GPR17 is involved in several physiological processes particularly in the regulation of inflammation and myelination within the central nervous system. It plays a critical role in the differentiation of oligodendrocyte precursor cells into mature oligodendrocytes which are essential for myelin sheath formation and repair of neural damage. GPR17 is not known to function as part of a larger receptor complex but it interacts with intracellular signaling pathways to modulate these cellular processes.

Pathways

GPR17 integrates into inflammatory response pathways and neural cell development pathways. It is actively involved in the nucleotide signaling pathway which is important for responses to tissue damage and initiating repair processes. GPR17 shares functional connections with proteins such as P2Y receptors which also respond to nucleotides and are involved in diverse cellular responses including muscle contraction and platelet aggregation.

GPR17's expression and role connect it to multiple sclerosis and brain ischemia. In multiple sclerosis dysregulation of GPR17 can affect the formation and maintenance of the myelin sheath contributing to neural degeneration. During brain ischemia GPR17 activation influences the extent of injury and subsequent recovery through its effects on inflammation and tissue repair. It is linked to proteins like CXCR7 which similarly influence neural damage and repair processes in ischemic conditions.

Product protocols

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Disease models & mechanisms 16: PubMed37990867

2023

Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.

Applications

Unspecified application

Species

Unspecified reactive species

Leonard D Kuhrt,Edyta Motta,Nirmeen Elmadany,Hannah Weidling,Raphaela Fritsche-Guenther,Ibrahim E Efe,Olivia Cobb,Jit Chatterjee,Lucy G Boggs,Marina Schnauß,Sebastian Diecke,Marcus Semtner,Corina Anastasaki,David H Gutmann,Helmut Kettenmann
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com